Healthcare / Medical Care FacilitiesKuala Lumpur
$0.20
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 23% · confianza 25%
FCF escenarios
weak_data · normalized FCF $16.6M · quality 83.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
48/100
C
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
12/100
SEC 0%
Sin guardar todavía.
Market Cap
$213M
P/E
19.5x
↓EV/EBITDA
7.6x
↓ROE
17.9%
↑Gross Margin
33.3%
↓Debt/Equity
0.17
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2024 · 2 años de histórico normalizado
Revenue CAGR
+3.7%
FCF CAGR
-15.3%
FCF margin
11.5%
FCF / Net income
0.80x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $104.3M · net income $15.0M · FCF $12.0M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | $104.3M | $104.3M | $99.9M | $97.1M |
| Net Income | $15.0M | $15.0M | $10.7M | $11.5M |
| EBITDA | $27.0M | $27.0M | $20.6M | $22.4M |
| EPS | 0.01 | 0.01 | 0.01 | 0.01 |
| Gross Margin | 33.3% | 33.3% | 36.3% | 28.2% |
| Operating Margin | 18.9% | 18.9% | 22.6% | 17.0% |
| Net Margin | 14.4% | 14.4% | 10.7% | 11.9% |
| Balance Sheet | ||||
| Debt/Equity | 0.17 | 0.17 | 0.16 | 0.17 |
| Current Ratio | 2.84 | 2.84 | — | — |
| Cash Flow | ||||
| Free Cash Flow | $12.0M | $12.0M | $16.6M | $16.7M |
| Returns | ||||
| ROE | 17.9% | 17.9% | 13.2% | 14.0% |
| Valuation | ||||
| P/E | 19.50 | 19.50 | — | — |
| EV/EBITDA | 7.56 | 7.56 | — | — |
| P/B | 2.53 | 2.53 | — | — |
| Growth & Yield | ||||
| Revenue Growth | 4.5% | 4.5% | 2.8% | — |
| EPS Growth | 40.2% | 40.2% | -7.1% | — |
| Dividend Yield | 1.2% | 1.2% | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
7.8%
EPS terminal req.
$0.02
Spread vs growth
32.3%
5Y implied EPS CAGR
8.7%
EPS terminal req.
$0.02
Spread vs growth
31.5%
10Y implied EPS CAGR
9.3%
EPS terminal req.
$0.03
Spread vs growth
30.8%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-14.0%
Start / end P/E
23.4x → 14.1x
EPS bridge
0.01 → 0.01
Residual
-15.9%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.